A COMMON ANTI-CMV DRUG, GANCICLOVIR, INHIBITS HIV-1 REPLICATION IN HUMAN TISSUES EX VIVO

Cytomegalovirus (CMV) is a common HIV-1 copathogen. Since CMV infection is an important contributor to immune activation, the driving force of HIV disease, an anti-CMV strategy might be beneficial to HIV-infected patients. Shin et al. reported that anti-CMV therapy with valganciclovir in coinfected...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:AIDS
Main Authors: Vanpouille, Christophe, Bernatchez, Jean A., Lisco, Andrea, Arakelyan, Anush, Saba, Elisa, Götte, Matthias, Margolis, Leonid
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5541768/
https://ncbi.nlm.nih.gov/pubmed/28657962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001532
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki